Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 543

1.

One-year functional outcomes of naturalistically treated patients with schizophrenia.

Spellmann I, Riedel M, Schennach R, Seemüller F, Obermeier M, Musil R, Jäger M, Schmauß M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ.

Psychiatry Res. 2012 Aug 15;198(3):378-85. doi: 10.1016/j.psychres.2011.12.047. Epub 2012 Mar 14.

PMID:
22421065
2.

Prediction of symptom remission in schizophrenia during inpatient treatment.

Jäger M, Riedel M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Bottlender R, Strauss A, Möller HJ.

World J Biol Psychiatry. 2009;10(4 Pt 2):426-34.

PMID:
17853260
3.

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.

Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Maier W, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Möller HJ, Riedel M.

Schizophr Res. 2009 Sep;113(2-3):210-7. doi: 10.1016/j.schres.2009.05.032. Epub 2009 Jun 27.

PMID:
19560901
4.

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.

Schennach-Wolff R, Meyer S, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M.

J Psychiatr Res. 2011 Dec;45(12):1639-47. doi: 10.1016/j.jpsychires.2011.07.014. Epub 2011 Aug 20.

PMID:
21862035
5.

Remission and recovery and their predictors in schizophrenia spectrum disorder: results from a 1-year follow-up naturalistic trial.

Schennach R, Riedel M, Obermeier M, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Seemüller F, Möller HJ.

Psychiatr Q. 2012 Jun;83(2):187-207. doi: 10.1007/s11126-011-9193-z.

PMID:
22038270
6.

Early-onset schizophrenia: a 15-year follow-up.

Röpcke B, Eggers C.

Eur Child Adolesc Psychiatry. 2005 Sep;14(6):341-50.

PMID:
16220219
7.

Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.

Chang WC, Ming Hui CL, Yan Wong GH, Wa Chan SK, Ming Lee EH, Hai Chen EY.

J Clin Psychiatry. 2013 Nov;74(11):e1046-53. doi: 10.4088/JCP.13m08355.

PMID:
24330905
8.

One year outcome in first episode schizophrenia. Predictors of relapse.

Uçok A, Polat A, Cakir S, Genç A.

Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):37-43. Epub 2005 Jul 18.

PMID:
16010602
9.

Symptomatic and functional remission in patients with first-episode psychosis.

Verma S, Subramaniam M, Abdin E, Poon LY, Chong SA.

Acta Psychiatr Scand. 2012 Oct;126(4):282-9. doi: 10.1111/j.1600-0447.2012.01883.x. Epub 2012 May 23.

PMID:
22616617
10.

The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.

Henry LP, Amminger GP, Harris MG, Yuen HP, Harrigan SM, Prosser AL, Schwartz OS, Farrelly SE, Herrman H, Jackson HJ, McGorry PD.

J Clin Psychiatry. 2010 Jun;71(6):716-28. doi: 10.4088/JCP.08m04846yel.

PMID:
20573330
11.

Remission in schizophrenia: a community-based 6-year follow-up study in Bali.

Kurihara T, Kato M, Reverger R, Tirta IG.

Psychiatry Clin Neurosci. 2011 Aug;65(5):476-82. doi: 10.1111/j.1440-1819.2011.02246.x.

12.

[Social outcome of schizophrenics in Tunisia: a transversal study of 60 patients].

Rafrafi R, Zaghdoudi L, Mahbouli M, Bouzid R, Labbane R, El Hechmi Z.

Encephale. 2009 Jun;35(3):234-40. doi: 10.1016/j.encep.2008.05.001. Epub 2008 Sep 23. French.

PMID:
19540409
13.

Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment.

Lambert M, De Marinis T, Pfeil J, Naber D, Schreiner A.

Eur Psychiatry. 2010 May;25(4):220-9. doi: 10.1016/j.eurpsy.2009.09.001. Epub 2009 Nov 18.

PMID:
19926263
16.

The Maudsley early onset schizophrenia study. Predictors of psychosocial outcome at 4-year follow-up.

Vyas NS, Hadjulis M, Vourdas A, Byrne P, Frangou S.

Eur Child Adolesc Psychiatry. 2007 Oct;16(7):465-70.

PMID:
17896122
17.

Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.

Jäger M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Riedel M, Bottlender R, Strauss A, Möller HJ.

Pharmacopsychiatry. 2008 Sep;41(5):190-5. doi: 10.1055/s-2008-1078745. Epub 2008 Sep 1.

PMID:
18763221
18.

The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis.

Jordan G, Lutgens D, Joober R, Lepage M, Iyer SN, Malla A.

J Clin Psychiatry. 2014 Jun;75(6):e566-72. doi: 10.4088/JCP.13m08606.

PMID:
25004197
19.

Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses.

Keshavan MS, Haas G, Miewald J, Montrose DM, Reddy R, Schooler NR, Sweeney JA.

Schizophr Bull. 2003;29(4):757-69.

PMID:
14989413
20.

Remission in schizophrenia: one-year Italian prospective study of risperidone long-acting injectable (RLAI) in patients with schizophrenia or schizoaffective disorder.

Rossi A, Bagalà A, Del Curatolo V, Scapati F, Bernareggi MM, Giustra MG; Risperidone Long-Acting Trial Investigators (R-LAI).

Hum Psychopharmacol. 2009 Oct;24(7):574-83. doi: 10.1002/hup.1067.

PMID:
19790173

Supplemental Content

Support Center